This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Brittany Savage: Innovator in Genetic Research
Introduction
Brittany Savage is a prominent inventor based in Tarrytown, NY (US). She has made significant contributions to the field of genetic research, particularly in the study of human chromosomes. Her work has the potential to impact various medical applications and enhance our understanding of genetic disorders.
Latest Patents
Brittany holds a patent for the invention titled "Human Chromosome 9 Open Reading Frame 72 (C9ORF72) iRNA Agent Compositions and Methods of Use Thereof." This patent represents her innovative approach to utilizing RNA agents in genetic research, which could lead to breakthroughs in treating genetic conditions.
Career Highlights
Brittany is currently employed at Alnylam Pharmaceuticals, Inc., a leading company in the field of RNA interference (RNAi) therapeutics. Her role at Alnylam allows her to collaborate with other experts in the field and contribute to cutting-edge research that aims to develop new treatments for various diseases.
Collaborations
Brittany works alongside talented colleagues, including Aarti Sharma-Kanning and Gustavo Droguett. Their combined expertise fosters a collaborative environment that enhances the research and development process at Alnylam Pharmaceuticals.
Conclusion
Brittany Savage is a dedicated inventor whose work in genetic research is paving the way for future innovations in medicine. Her contributions, particularly through her patent, highlight her commitment to advancing scientific knowledge and improving healthcare outcomes.